✦ LIBER ✦

Impact ofCYP2D6*10on mexiletine pharmacokinetics in healthy adult volunteers

✍ Scribed by Masahiro Otani; Tsuyoshi Fukuda; Masakazu Naohara; Hiromi Maune; Chiaki Senda; Isamu Yamamoto; Junichi Azuma

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of CYP2D6*10 on the pharmacoki

✍ S. K. Jin; H. J. Chung; M. W. Chung; J.-I. Kim; J.-H. Kang; S. W. Woo; S. Bang; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

Impact ofCYP2D6*10on H1-antihistamine-in

✍ Junji Saruwatari; Masayuki Matsunaga; Kazuyuki Ikeda; Masashi Nakao; Kentaro Oni 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 187 KB

The pharmacokinetics of ofloxacin in hea

✍ A. Leroy; F. Borsa; G. Humbert; P. Bernadet; J. P. Fillastre 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 125 KB

Pharmacokinetics of buccal and intranasa

✍ Mark Anderson; Parag Tambe; Helen Sammons; Hussain Mulla; Richard Cole; Imti Cho 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 152 KB

Pharmacokinetics and absolute bioavailab

✍ D. A. Goldstein; Y. K. Tan; S. J. Soldin 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 301 KB

Effect ofCYP2D6genotype on flecainide ph

✍ Kosuke Doki; Masato Homma; Keisuke Kuga; Kazutomi Kusano; Shigeyuki Watanabe; Iw 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 202 KB